Trending

Tagrisso

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

AstraZeneca has widened the licence for its cancer drug Tagrisso (osimertinib) in Europe after regulators gave it the

X

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

https://pharmaphorum.com/news/az-tagrisso-nsclc-egfr-europe/

AZ’s Tagrisso gets full US approval in lung cancer

AZ’s Tagrisso gets full US approval in lung cancer

Phase 3 data confirmed its efficacy in patients with a certain mutation.

X

AZ’s Tagrisso gets full US approval in lung cancer

https://pharmaphorum.com/news/azs-tagrisso-gets-full-us-approval-lung-cancer/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com